New review summarizes current knowledge on the mechanisms, evaluation and management of bone fragility in type 1 diabetes; calls for regular evaluation of fracture risk as well as more research into the role of osteoporosis drugs in diabetic patients.
Despite an up to six-fold increased risk of broken bones in patients with type 1 diabetes mellitus (T1DM), the relationship between diabetes and osteoporosis has, until recently, suffered from a general lack of attention and research. As a result, health professionals who treat diabetic patients often do not recognize that fragility fractures are a major complication of the disease.
